Tenet Healthcare Corporation $THC Shares Sold by Private Management Group Inc.

Private Management Group Inc. trimmed its position in Tenet Healthcare Corporation (NYSE:THC) by 9.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,087 shares of the company’s stock after selling 6,520 shares during the period. Private Management Group Inc.’s holdings in Tenet Healthcare were worth $12,338,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Triumph Capital Management acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the fourth quarter valued at approximately $29,000. Meeder Asset Management Inc. raised its holdings in shares of Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after buying an additional 114 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Tenet Healthcare in the second quarter worth $35,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the transaction, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on THC shares. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. UBS Group raised their price target on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Wells Fargo & Company decreased their price target on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Guggenheim reduced their target price on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Stock Up 5.3%

THC opened at $173.54 on Friday. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The company has a fifty day moving average of $184.25 and a two-hundred day moving average of $200.12. The stock has a market capitalization of $14.95 billion, a price-to-earnings ratio of 9.02, a PEG ratio of 1.36 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the previous year, the company earned $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.